Posted in | News | Business

GrafTech Receives Second Request from DOJ Regarding Proposed Acquisitions

GrafTech International Ltd. (NYSE:GTI) today announced that it has received a request for additional information and documentary material from the Antitrust Division of the U.S. Department of Justice (DOJ) regarding GrafTech’s proposed acquisitions of Seadrift Coke L.P. and C/G Electrodes LLC.

The request for additional information and material, commonly referred to as a “Second Request”, is part of a customary antitrust regulatory review process. Completion of the acquisitions is subject to compliance with applicable DOJ clearance procedures as well as other customary closing conditions. GrafTech intends to reply to the request promptly and continues to expect the two acquisitions to close in 2010.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    GrafTech International. (2019, February 10). GrafTech Receives Second Request from DOJ Regarding Proposed Acquisitions. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=22044.

  • MLA

    GrafTech International. "GrafTech Receives Second Request from DOJ Regarding Proposed Acquisitions". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=22044>.

  • Chicago

    GrafTech International. "GrafTech Receives Second Request from DOJ Regarding Proposed Acquisitions". AZoM. https://www.azom.com/news.aspx?newsID=22044. (accessed November 21, 2024).

  • Harvard

    GrafTech International. 2019. GrafTech Receives Second Request from DOJ Regarding Proposed Acquisitions. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=22044.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.